DSIP

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a small, naturally occurring neuropeptide made up of nine amino acids. It was first isolated from the cerebral venous blood of rabbits during induced slow-wave (delta) sleep, which is how it earned its name — though decades of research have shown its biology is more nuanced than the name suggests.

Rather than acting as a sedative or hypnotic, DSIP is best understood as a neuromodulator: a signaling molecule that appears to nudge the brain's own sleep-regulating and stress-response systems rather than switching them off. It is not an FDA-approved drug. In the United States it is available only as a pharmacy-compounded preparation prescribed under physician supervision.

How DSIP works

DSIP's mechanism remains only partly understood, which we state plainly. The peptide is found throughout the brain and periphery and interacts with several systems at once, so no single receptor fully explains its effects. The prevailing view is that it modulates sleep architecture — favoring deeper slow-wave stages — rather than forcing sleep the way GABAergic sedatives do.

Preclinical work has linked DSIP to modulation of the hypothalamic-pituitary-adrenal (HPA) axis, effects on corticotropin and other hormones, and antioxidant and stress-buffering activity. Some studies describe influence on glutamatergic and GABAergic tone and on circadian signaling. Together these point to a regulatory, homeostatic role rather than a direct hypnotic one.

Because DSIP behaves as a modulator with broad, low-intensity effects, its actions in humans are subtle and variable between individuals — a theme that runs through both its mechanistic and its clinical literature.

What DSIP is used for

What the evidence shows

Human data on DSIP are limited and decades old. Early clinical work reported that DSIP could improve sleep and normalize disturbed sleep-wake patterns in some patients, with a broad, multifunctional psychophysiological profile rather than a simple sedative effect [1][2].

That said, the studies are small, methodologically dated, and not consistently replicated, and later reviews have candidly described DSIP as a still-unresolved puzzle whose endogenous role and therapeutic value are not settled [3]. There are no large, modern randomized controlled trials establishing efficacy for insomnia or any sleep disorder.

We share this honestly with every patient. DSIP is used in clinical practice on the strength of its favorable tolerability and its distinctive, non-sedating mechanism — not on the basis of definitive human efficacy trials. If you are expecting a reliable sleeping pill, DSIP is not that; if you are exploring a gentler modulator of sleep depth under medical supervision, that context matters.

Dosing & administration context

DSIP is typically administered by subcutaneous injection, and its short biological half-life means timing relative to the sleep period is part of how physicians think about it. Protocols in clinical use are individualized and generally conservative, reflecting the peptide's subtle effects and the thinness of the dosing literature.

The specific dose, timing, frequency, and duration are set by the prescribing physician based on your sleep history, other medications, and your response — which is why we frame this as clinical context, not a self-dosing guide. DSIP obtained without a prescription (research-only vials, gray-market powders) carries no guarantee of identity, purity, or sterility.

DSIP is not an FDA-approved medication. Content on this page is clinical context for physician-supervised, pharmacy-compounded use — not a dosing guide or a substitute for medical advice.

Safety & side effects

DSIP has generally been reported as well tolerated in the available human studies, with a low burden of side effects and no established pattern of serious toxicity. Because it does not act as a classic sedative, it has not been associated with the next-day grogginess or dependence risk seen with some sleep drugs — though this should not be read as proof of long-term safety.

Human safety data are limited and dated, so we screen carefully before prescribing and monitor throughout a course. The most important safety principle is source control: a pharmacy-compounded product from a licensed 503A or 503B pharmacy is a fundamentally different risk profile than a research vial of unknown origin.

How Strong Health prescribes DSIP

At Strong Health, DSIP is prescribed only after a physician evaluation that includes a review of your sleep history, current medications, and — where relevant — screening for underlying sleep disorders such as sleep apnea that deserve their own workup. Evaluations are done in person at our Miami (Brickell) clinic or via telehealth.

It is dispensed exclusively through licensed 503A or 503B compounding pharmacies under physician orders; we do not sell or recommend research-only product. We treat DSIP as one part of a broader sleep plan — alongside sleep hygiene, timing, and any indicated medical evaluation — rather than a standalone fix, and your physician reviews your response at scheduled intervals and adjusts or stops treatment accordingly.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions